Phantom1 says:
>It would seem that missing one third of cells may be a problem? Doesn't seem all that good compared to other tech. and ways of getting into cells.
What methods are referring to?
Do you have any references on relative efficiencies?
I have reviewed the available literature - efficiency data and predications are scarce. Here is an example, in the RNAi space, of what I am looking for:
http://nar.oxfordjournals.org/content/33/3/e30.long
going intracellular, page-45
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $519.2K | 5.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 182466 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 101115 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |